Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: A double-blind placebo-controlled trial

Archives of Internal Medicine

Volumn 163, Issue 6, 2003, Pages 720-727

  Percheron, Gaëlle ^a   Hogrel, Jean Yves ^a   Denot Ledunois, Sonjà ^a   Fayet, Guillemette ^a   Forette, Françoise ^b   Baulieu, Etienne Emile ^c   Fardeau, Michel ^a   Marini, Jean François ^d,e  

^a Institut de Myologie   (France)

^b AP HP   (France)

^c INSERM   (France)

^d CNRS   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

AGED; AGING; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FRANCE; HAND GRIP; HUMAN; KNEE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSCLE EXAMINATION; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THIGH; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AGING; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRANCE; HAND STRENGTH; HUMANS; KNEE; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0037463821     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.6.720     Document Type: Article

References (30)

1. Larsson L, Grimby G, Karlsson J. Muscle strength and speed movement in relation to age and muscle morphology. J Appl Physiol. 1979;46:451-456.
2. Kallman DA, Plato CC, Tobin JD. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol. 1990;45:M82-M88.
3. Young A, Stokes M, Crowe M. The size and strength of the quadriceps muscles of old and young men. Clin Physiol. 1985;5:145-154.
4. Klitgaard H, Mantoni M, Schiaffino S, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990;140:41-54.
5. Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol. 1991;71:644-650.
6. Overend TJ, Cunningham DA, Kramer JF, Lefcoe MS, Paterson DH. Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men. J Gerontol. 1992;47:M204-M210.
7. Danneskiold-Samsoe B, Kofod V, Munter J, Grimby G, Schnohr P, Jensen G. Muscle strength and functional capacity in 78-81-year-old men and women. Eur J Appl Physiol Occup Physiol. 1984;52:310-314.
8. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995;50(Spec No):11-16.
9. Hakkinen K, Kraemer WJ, Kallinen M, Linnamo V, Pastinen UM, Newton RU. Bilateral and unilateral neuromuscular function and muscle cross-sectional area in middle-aged and elderly men and women. J Gerontol A Biol Sci Med Sci. 1996;51:B21-B29.
10. Murray MP, Duthie EH Jr, Gambert SR, Sepic SB, Mollinger LA. Age-related differences in knee muscle strength in normal women. J Gerontol. 1985;40:275-280.
11. Baulieu EE. Studies on dehydroepiandrosterone (DHEA) and its sulfate during aging. C R Acad Sci III. 1995;318:7-11.
12. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 1992;75:1002-1004
13. Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B. Serum DHEAS levels as an individual marker. J Clin Endocrinol Metab. 1994;79:1273-1276.
14. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab. 1996;81:3147-3151.
15. Nestler JE. Advances in understanding the regulation and biologic actions of dehydroepiandrosterone. Curr Opin Endocrinol Diabetes. 1996;3:202-211.
16. Khorram O. DHEA: a hormone with multiple effects. Curr Opin Obstet Gynecol. 1996;8:351-354.
17. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A. 1996;93:13410-13415.
18. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78:1360-1367.
19. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U SA. 2000;97:4279-4284.
20. Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women: potential remedial effects. Ann N Y Acad Sci. 1995;774:128-142.
21. Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol. 1996;150(suppl):S43-S50.
22. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). 1998;49:421-432.
23. Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab. 2000;85:3208-3217.
24. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984;9:222-226.
25. Desrosiers J, Bravo G, Hébert R, Mercier L. Impact of elbow position on grip strength of elderly men. J Hand Ther. 1995;8:27-30.
26. Labrie F, Bélanger A, Van LT, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 1998;63:322-328.
27. Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995;269(pt 1):E820-E826.
28. Fryburg DA, Jahn LA, Hill SA, Oliveras DM, Barett EJ. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J Clin Invest. 1995;96:1722-1729.
29. Ravaglia G, Forti P, Maioli F, et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old: results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 1996;81:1173-1178.
30. Bross R, Casaburi R, Storer TW, Bhasin S. Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states. Baillieres Clin Endocrinol Metab. 1998;12:365-378.